Exelixis (EXEL) Times Interest Earned (2010 - 2018)
Exelixis (EXEL) recorded quarterly Times Interest Earned of -$111602.0 in Q4 2018, down 189.16% quarter-over-quarter from $125176.0 in Q3 2018.
Exelixis (EXEL) Times Interest Earned (2010 - 2018) Analysis & Trends
Exelixis' Times Interest Earned history runs 9 years deep, the most recent figure standing at -$111602.0 for Q4 2018.
- In Q4 2018, Times Interest Earned changed N/A year-over-year to -$111602.0; the TTM figure through Sep 2019 stood at -$403756.0 (down 210.71% YoY), while the FY2017 annual figure was $19.12, up 2347.13% from the prior year.
- Times Interest Earned was -$111602.0 for Q4 2018 at Exelixis, down from $125176.0 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $125176.0 in Q3 2018 to a low of -$111602.0 in Q4 2018.
- Historically, Times Interest Earned has averaged $904.15 across 5 years, with a median of -$2.62 in 2015.
- The sharpest annual moves came in 2016 and 2017: Times Interest Earned plunged 160.21% in 2016, then jumped 364.69% in 2017.
- A 5-year view of Times Interest Earned shows it stood at -$8.82 in 2014, then soared by 59.6% to -$3.56 in 2015, then surged by 526.23% to $15.19 in 2016, then slumped by 58.1% to $6.37 in 2017, then plunged by 1753181.25% to -$111602.0 in 2018.
- The last three Times Interest Earned figures came in at -$111602.0 (Q4 2018), $125176.0 (Q3 2018), and $6.37 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Exelixis | 13.37 Bn | 12.59 Bn | 590.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2018 | -111,602.00 |
| Sep 28, 2018 | 125,176.00 |
| Jun 30, 2017 | 6.37 |
| Mar 31, 2017 | 4.57 |
| Dec 30, 2016 | 15.19 |
| Sep 30, 2016 | 0.93 |
| Jun 30, 2016 | -2.41 |
| Mar 31, 2016 | -4.78 |
| Sep 30, 2015 | -3.56 |
| Jun 30, 2015 | -2.62 |
| Mar 31, 2015 | -1.84 |
| Dec 31, 2014 | -8.82 |
| Sep 30, 2014 | -4.20 |
| Jun 30, 2014 | -5.11 |
| Mar 31, 2014 | -5.53 |
| Dec 31, 2013 | -11.78 |
| Sep 30, 2013 | -4.89 |
| Jun 30, 2013 | -4.56 |
| Mar 31, 2013 | -3.08 |
| Dec 31, 2012 | -4.66 |